TRADENAME: TAGONIB

ACTIVE PRINCIPLE: Imatinib

PRESENTATIONS FOR SALE:

100 mg x 180 Comp. Rec.

400 mg x 30 Comp. Rec.

THERAPEUTIC ACTION: Antineoplastic agent.

Protein tyrosine kinase inhibitor.